Immunity to Lyme disease: Protection, pathology and persistence

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 503-509

  Seiler, Kathleen Petri ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL IMMUNITY; BORRELIA BURGDORFERI; IMMUNE RESPONSE; LYME DISEASE; PATHOLOGY; PERSISTENT INFECTION; REVIEW;

EID: 0030218954     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80038-0     Document Type: Article

References (93)

1. Nocton JJ, Steere AC. Lyme disease. of outstanding interest Adv Int Med. 40:1995;69-117 An excellent on the epidemiology and clinical aspects of Lyme disease.
2. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med. 330:1994;229-234.
3. Barthold SW, De Souza MS, Janotka JL, Smith AL, Persing DH. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol. 143:1993;959-971.
4. Yang L, Weis JH, Eichwald E, Kolbert CP, Persing DH, Weis JJ. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun. 62:1994;492-500.
5. Barthold SW, Bockenstedt LK. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun. 61:1993;4696-4702.
6. Schaible UE, Wallich R, Kramer MD, Nerz G, Stehle T, Museteanu C, Simon MM. Protection against Borrelia burgdorferi infection in scid mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol. 6:1994;671-681.
7. Augero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. of outstanding interest J Clin Microbiol. 34:1996;1-9 Serially collected sera from 46 patients infected with B. burgdorferi were assessed for IgM and IgG responses.
8. Coleman JL, Rogers RC, Benach JL. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect Immun. 60:1992;3098-3104.
9. Sadziene A, Rosa PA, Thompson PA, Hogan DM, Barbour AG. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med. 176:1992;799-809.
10. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 250:1990;553-555.
11. Fikrig E, Telford SR III, Barthold SW, Kantor FS, Spielman A, Flavell RA. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci USA. 89:1992;5418-5421.
12. Barthold SW. Lyme borreliosis in the laboratory mouse. J Spirochetal Tick-borne Dis. 3:1996;22-44.
13. Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine. 13:1995;435-441.
14. Lovrich SD, Callister SM, DuChateau BK, Lim LCL, Winfrey J, Day SP, Schell RF. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. of outstanding interest Infect Immun. 63:1995;2113-2119 Recombinant OspA protein was produced from B. burgdorferi sensu stricto, and from the related B. burgdorferi sensu lato strains (B. afzelli and B. garinii). OspA induced protective immunity was not found to extend to isolates from heterologous species.
15. Dunne M, Al-Ramadi BK, Barthold SW, Flavell RA, Fiknig E. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect Immun. 63:1995;1611-1614.
16. Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG. Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med. 178:1993;197-209.
17. Simon MM, Schaible UU, Kramer MD, Eckerskom C, Museteanu C, Muller-Hermelink HK, Wallich R. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis. 164:1991;123-132.
18. Schoen RT, Meurice F, Brunet CM, Cretella S, Krause DS, Craft JE, Fikrig E. Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease. of special interest J Infect Dis. 172:1995;1324-1329 This study demonstrates the safety of the OspA vaccine, even in individuals previously exposed to B. burgdorferi.
19. Keller D, Koster FT, Marks DH, Hosbach P, Erdile LF, Mays JP. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA. 271:1994;1764-1768.
20. Fikrig E, Telford SR III, Wallich R, Chen M, Lobet Y, Matuschka FR, Kimsley RB, Kantor FS, Barthold SW, Spielman A, Flavell RA. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med. 181:1995;215-221.
21. Johnson BJB, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine. 13:1995;1086-1094.
22. De Silva AM, Telford SR III, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. of outstanding interest J Exp Med. 183:1996;271-275 This study shows the loss of OspA on the spirochete within the tick as it takes the blood meal. It also demonstrates that antibodies to OspA work within the vector only during a limited portion of the tick's blood meal.
23. Probert WS, LeFebvre RB. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83 kilodalton antigen. Infect Immun. 62:1994;1920-1926.
24. Nguyen T-PK, Lam TT, Barthold SW, Telford SR, Flavell RA, Fikrig E. Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun. 62:1994;2079-2084.
25. Barthold SW, Fikrig E, Bockenstedt LK, Persing DH. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. of outstanding interest Infect Immun. 63:1995;2255-2261 Mice were immunized with OspA, then challenged with cultured organisms or organisms present in skin grafted from an infected mouse. Immunized mice challenged with transplants were susceptible to infection, developing carditis and joint inflammation as well. This study shows that spirochetes alter their surface antigens while in the mouse host.
26. Hughes CAN, Engstrom SM, Coleman LA, Kodner CB, Johnson RC. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect Immun. 61:1993;5115-5122.
27. Sadziene A, Thompson PA, Barbour AG. A flagella-less mutant of Borrelia burgdorferi as a live attenuated vaccine in the murine model of Lyme disease. J Infect Dis. 173:1996;1184-1193.
28. Cadavid D, Thomas DD, Crawley R, Barbour AG. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med. 179:1994;631-642.
29. Fikrig E, Barthold SW, Flavell RA. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun. 61:1993;2553-2557.
30. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. of outstanding interest Proc Natl Acad Sci USA. 92:1995;2909-2913 A change in surface Osp expression from OspA to OspC was observed when cultured B. burgdorferi were shifted from 25° to 37°C. In the tick, it took both a temperature shift and blood meal to alter spirochete protein expression. This study shows that B. burgdorferi alteration in Osp expression occurs within the tick vector.
31. Burkot TR, Piesman J, Wirtz RA. Quantitation of the Borrelia burgdorferi outer surface protein A in lxodes scapularis: fluctuations during the tick life cycle, doubling times, and loss while feeding. J Infect Dis. 170:1994;883-889.
32. Stevenson B, Schwan TG, Rosa PA. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. of outstanding interest Infect Immun. 63:1995;4535-4539 B. burgdorferi were cultured at 23° and 35°C with expression of OspE and OspF occurring only at the higher temperature. This study shows that ability of B. burgdorferi to alter its surface antigen expression depending on its environment.
33. Champion CI, Blanco DR, Skare JT, Haake DA, Giladi M, Foley D, Miller JN, Lovett MA. A 9.0 kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun. 62:1994;2653-2661.
34. Suk K, Das S, Sun W, Jwang B, Barthold SW, Flavell RA, Fikrig E. Borrelia burgdorferi genes selectively expressed in the infected host. of outstanding interest Proc Natl Acad Sci USA. 92:1995;4269-4273 Screening of a B. burgdorferi library with infected mouse sera identified a novel protein, p21, expressed only in infected mice and not on cultured spirochetes. This provides further evidence for surface antigen modulation of B. burgdorferi during infection of the mammalian host.
35. Ramamoorthy R, Povinelli L, Philipp MT. Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi. of special interest Infect Immun. 64:1996;1259-1264 A B. burgdorferi expression library was screened with serum from an infected monkey. BmpA and bmpD gene products reacted with infected monkey sera but were not expressed by cultured spirochetes, providing more evidence for antigenic modulation.
36. Wallich R, Brenner C, Kramer MD, Simon MM. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. of special interest Infect Immun. 63:1995;3327-3335 A novel gene, pG, is described which is expressed by B. burgdorferi during infection in vivo, but not found on cultured organisms. pG shows highest sequence similarity to OspF. Mice receiving immune sera raised against recombinant pG had delayed arthritis development upon infection. This is further evidence for antigenic modulation in vivo.
37. Akins DR, Porcella SF, Popova TG, Shevchenko D, Baker SI, Li M, Norgard MV, Radolf JD. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. of special interest Mol Microbiol. 18:1995;507-520 This study provides evidence for the expression of an OspF homologue by B. burgdorferi in infected animals but not in cultured organisms, and provides more evidence for surface antigen modulation.
38. Montgomery RM, Malawista SE, Feen KJM, Bockenstedt LK. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. of special interest J Exp Med. 183:1996;261-269 Antigenic switching was directly demonstrated by fluorescent antibody staining of freshly recovered B. burgdorferi from infected mice. The infecting culture expressed only OspA whereas by 30 days post-infection spirochetes recovered from the peritoneum expressed only OspC.
39. Golde WT, Dolan MC. Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural zoonotic cycle compared with maintenance in culture. of special interest Infect Immun. 63:1995;4795-4801 B. burgdorferi was reisolated from mouse skin at the fifth zoonotic cycle and compared with the cultured parent strain. Analysis with monoclonal antibodies showed differential expression of a subset of antigens between parent and reisolate, providing more evidence for surface antigen modulation while in the mammal or tick.
40. Stevenson B, Bockenstedt LK, Barthold SW. Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. Infect Immun. 62:1994;3568-3571.
41. Persing DH, Mathiesen D, Podzorski D, Barthold SW. Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice. Infect Immun. 62:1994;3521-3527.
42. Jonsson M, Bergstrom S. Transcriptional and translational regulation of the expression of the major outer surface proteins in Lyme disease Borrelia strains. Microbiology. 141:1995;1321-1329.
43. Margolis N, Rosa PA. Regulation of expression of major outer surface proteins in Borrelia burgdorferi. Infect Immun. 61:1993;2207-2210.
44. Weiss JJ, Ma Y, Erdile LF. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun. 62:1994;4632-4636.
45. 3Cys) modified peptide.
46. Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weiss JJ. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide by the cytokine-inducible pathway. Infect Immun. 62:1994;3663-3671.
47. Ma Y, Weiss JJ. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun. 61:1993;3843-3853.
48. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. J Immunol. 147:1991;1968-1974.
49. Honarvar N, Schaible UE, Galanos C, Wallich R, Simon MM. A 14 000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology. 82:1994;389-396.
50. Whitmire WM, Garon CF. Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi. Infect Immun. 61:1993;1460-1467.
51. Norgard MV, Riley BS, Richardson JA, Radolf JD. Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. of special interest Infect Immun. 63:1995;1507-1515 Injection of synthetic lipopeptides based on the structure of OspA and OspB induced inflammatory infiltration into dermal tissue characteristic of the skin lesions of Lyme disease and syphilis.
52. Gondolf KB, Mihatsch M, Curschellas E, Dunn JJ, Batsford SR. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum. 37:1994;1070-1077.
53. Tatro JB, Romero LI, Beasley D, Steere AC, Reichlin S. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and IL-6 production in cultured rat brain cells. J Infect Dis. 169:1994;1014-1022.
54. Defosse DL, Johnson RC. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun. 60:1992;1109-1113.
55. Habicht GS, Beck G, Benach JL, Coleman JL, Leichtling KD. Lyme disease spirochetes induce human and murine interleukin-1 production. J Immunol. 134:1985;3147-3154.
56. Habicht GS, Katona LI, Benach JL. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis. 164:1991;568-574.
57. Kenefick KB, Lim LCL, Alder JD, Schmitz FL, Czurprynski CJ, Schell RF. Induction of interleukin-1 release by high and low passage isolates of Borrelia burgdorferi. J Infect Dis. 167:1993;1086-1092.
58. Miller LC, Isa S, Vannier E, Georgilis K, Steere AC, Dinarello CA. Live Borrelia burgdorferi preferentially activate interleukin-1β gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest. 90:1992;906-912.
59. Schaible UE, Gay S, Museteanu C, Kramer MD, Zimmer G, Eichmann K, Museteanu U, Simon MM. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol. 137:1990;811-820.
60. Barthold SW, Sidman CL, Smith AL. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg. 47:1992;605-613.
61. Barthold SW, De Souza M. Exacerbation of Lyme arthritis in beige mice. of special interest J Infect Dis. 172:1995;778-784 This study shows that mice with the beige mutation develop Lyme arthritis when infected with B. burgdorferi, whereas the congenic C57/BL6 parent strain does not. This study demonstrates that the granule defect in neutrophils in the beige mice is primarily involved in the development of the pathology, presumably by allowing expansion of spirochetes in vivo.
62. + T cell interactions. J Infect Dis. 171:1995;362-370.
63. Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64 000 MW protein. J Infect Dis. 167:1993;1372-1378.
64. Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology. 38:1988;1439-1442.
65. Fikrig E, Berland R, Chen M, Williams S, Sigal LH, Flavell RA. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. Proc Natl Acad Sci USA. 90:1993;183-187.
66. Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 26:1989;732-737.
67. Garcia-Monco JC, Wheeler CM, Benach JL, Furie MB, Lukehart SA, Stanek G, Steere AC. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci. 117:1993;206-214.
68. Garcia-Monco JC, Seidman RJ, Benach JL. Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun. 63:1995;4130-4137.
69. Kalish RA, Leong JL, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 61:1993;2774-2779.
70. Steere AC, Dwyer ED, Winchester R. Association of chronic Lyme arthritis with the HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 323:1990;219-223.
71. Lengl-Janßen B, Strauss AF, Steere AC, Kamradt T. The T-helper response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med. 180:1994;2069-2078.
72. Kamradt T, Lengl-Janßen B, Strauss AF, Bansal G, Steere AC. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. of special interest Infect Immun. 64:1996;1284-1289 The prevalence of T-cell lines directed to OspA from patients with treatment-resistant Lyme arthritis was further characterized by peptide mapping. Dominant epitopes of OspA were recognized by patients' T cells, suggesting the existence of an arthritogenic epitope.
73. + T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect Immun. 63:1995;4818-4825.
74. + T cell clone. Cell Immunol. 162:1995;225-234.
75. Matyniak JE, Reiner SL. T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med. 181:1995;1251-1254.
76. Keane-Myers A, Nickell SP. T-cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol. 154:1995;1770-1776.
77. Keane-Myers A, Nickell SP. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J Immunol. 155:1995;2020-2028.
78. Anguita J, Persing DH, Rincon M, Barthold SW, Fikrig E. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J Clin Invest. 97:1996;1028-1034.
79. Keane-Myers A, Maliszewski CR, Finkelman FD, Nickell SP. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J Immunol. 156:1996;2488-2494.
80. Yssel H, Shanafelt M-C, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med. 174:1991;593-601.
81. Foley DM, Gayek RJ, Skare JT, Wagar EA, Champion CI, Blanco DR, Lovett MA, Miller JN. Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity. J Clin Invest. 96:1995;965-975.
82. Pachner AR, Braswell ST, Delaney E, Amemiya K, Major E. A rabbit model of Lyme neuroborreliosis: characterization by PCR, serology and sequencing of the OspA gene from brain. Neurology. 44:1994;1938-1943.
83. Pachner AR, Delaney E, O'Neill T, Major E. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology. 45:1995;165-172.
84. Philipp MT, Johnson BJB. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol. 2:1994;431-443.
85. Philipp MT, Aydintug MK, Bohm RP, Cogswell FB, Dennis VA, Lanners HN, Lowrie RC, Roberts ED, Conway MD, Karacorlu M, et al. Early and early disseminated phases of Lyme disease in the Rhesus monkey: a model for infection in humans. Infect Immun. 61:1993;3047-3059.
86. Roberts ED, Bohm RP, Cogswell FB, Lanner HN, Lowrie RC, Pivinelli L, Piesman J, Philipp MT. Chronic Lyme disease in the Rhesus monkey. Lab Invest. 72:1995;146-160.
87. Pachner AR, Basta J, Delaney E, Hulinska D. Localization of Borrelia burgdorferi in murine lyme borreliosis by electron microscopy. of special interest Am J Trop Med Hyg. 52:1995;128-133 Electron microscopy of mouse hearts infected with B. burgdorferi revealed the majority of spirochetes in extracellular spaces and showed many bacteria in collagen deposits. Inflammation was patchy and was not in the same areas as the spirochetes. This study shows that B. burgdorferi was mostly extracellular during infection of the mouse host, although occasionally intracellular organisms were seen.
88. Comstock LE, Thomas DD. Characterization of Borrelia burgdorferi invasion of cultured endothelial cells. Microb Pathog. 10:1991;137-148.
89. Klempner MS, Noring R, Rogers RA. Invasion of humanskin fibroblasts by the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis. 167:1992;1074-1081.
90. Montgomery RR, Nathanson MH, Malawista SE. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. J Immunol. 150:1993;909-915.
91. Szczepanski A, Furie MB, Benach JL, Lane BP, Fleit HB. Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest. 85:1990;1637-1647.
92. Ma Y, Sturrock A, Weiss JJ. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun. 59:1991;671-678.
93. Seiler KP, Vavrin Z, Eichwald E, Hibbs JB, Weis JJ. Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. of outstanding interest Infect Immun. 63:1995;3886-3895 This study shows that although infection with B. burgdorferi induces nitric oxide production in the mouse, nitric oxide is not involved in host resistance or in arthritis development. This study supports the idea that B. burgdorferi is not intracellular during an essential part of its life within the mammal.